We are live on ! Find out more
BLFS icon

BioLife Solutions

156 hedge funds and large institutions have $897M invested in BioLife Solutions in 2023 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 61 increasing their positions, 53 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more funds holding in top 10

Funds holding in top 10: 35 (+2)

15% more repeat investments, than reductions

Existing positions increased: 61 | Existing positions reduced: 53

5% more capital invested

Capital invested by funds: $850M → $897M (+$46.6M)

2.63% more ownership

Funds ownership: 90.67%93.3% (+2.6%)

8% less funds holding

Funds holding: 169156 (-13)

59% less call options, than puts

Call options by funds: $570K | Put options by funds: $1.38M

59% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 22

Holders
156
Holders Change
-13
Holders Change %
-7.69%
% of All Funds
2.45%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.08%
New
9
Increased
61
Reduced
53
Closed
22
Calls
$570K
Puts
$1.38M
Net Calls
-$809K
Net Calls Change
-$1.16M
Name Holding Trade Value Shares
Change
Change in
Stake
CC
1
Casdin Capital
New York
$171M +$3.16M +150,000 +2%
BlackRock
2
BlackRock
New York
$118M -$1.41M -66,912 -1%
Vanguard Group
3
Vanguard Group
Pennsylvania
$56.6M +$1.51M +71,667 +3%
PWAM
4
Park West Asset Management
California
$46M +$13.2M +627,954 +43%
FAM
5
Fred Alger Management
New York
$45.8M +$3.12M +147,899 +8%
GCM
6
Geneva Capital Management
Wisconsin
$34.5M +$57.9K +2,750 +0.2%
State Street
7
State Street
Massachusetts
$25.5M +$1.21M +57,646 +5%
PCM
8
Palisade Capital Management
New Jersey
$25.1M +$1.15M +54,538 +5%
Invesco
9
Invesco
Georgia
$21.8M +$3.79M +179,950 +22%
Ameriprise
10
Ameriprise
Minnesota
$21.2M -$62.7K -2,976 -0.3%
GIM
11
Granahan Investment Management
Massachusetts
$20.9M +$1.96M +92,991 +11%
Millennium Management
12
Millennium Management
New York
$15.9M +$5.02M +238,402 +50%
Jennison Associates
13
Jennison Associates
New York
$15.6M -$4.62M -219,261 -24%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$15.5M +$737K +35,015 +5%
GS
15
Gagnon Securities
New York
$14.1M -$260K -12,342 -2%
Dimensional Fund Advisors
16
Dimensional Fund Advisors
Texas
$14.1M +$3.12M +148,327 +30%
VOYA Investment Management
17
VOYA Investment Management
Georgia
$10.4M +$9.64M +457,702 +3,511%
JP Morgan Chase
18
JP Morgan Chase
New York
$8.91M -$42.8K -2,031 -0.5%
BCIM
19
British Columbia Investment Management
British Columbia, Canada
$8.84M
Northern Trust
20
Northern Trust
Illinois
$8.78M +$338K +16,056 +4%
Morgan Stanley
21
Morgan Stanley
New York
$8.67M -$528K -25,071 -6%
HRCM
22
Hood River Capital Management
Florida
$8.61M +$8.2M +389,522 New
New York State Common Retirement Fund
23
New York State Common Retirement Fund
New York
$8.29M +$262K +12,442 +3%
PCM
24
Peregrine Capital Management
Minnesota
$8.08M -$2.38K -113 -0%
GA
25
Gagnon Advisors
New York
$7.97M

BLFS Hedge Fund Activity: Q2 2023 in Review

156 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in BioLife Solutions (BLFS) for Q2 2023, worth a combined $897M — up 5.5% from $850M a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of BLFS and 9 opened new positions — a net loss of 13 holders — while 53 trimmed existing stakes and 61 added.

The largest buyer was Park West Asset Management, adding an estimated $13.2M. The largest seller was Mirabella Financial Services, exiting entirely with an estimated $7.28M sold.

  • 156 institutional investors held BioLife Solutions (BLFS) as of Q2 2023, down from 169 in Q1 2023.
  • Funds reported $897M of BioLife Solutions stock for Q2 2023, up 5.5% quarter-over-quarter.
  • 9 funds opened new BioLife Solutions positions in Q2 2023 and 22 closed out, a net change of -13 holders.
  • The largest BioLife Solutions buyer in Q2 2023 was Park West Asset Management, an estimated $13.2M added.
  • The largest BioLife Solutions seller in Q2 2023 was Mirabella Financial Services, an estimated $7.28M sold.

Based on aggregated 13F filings for Q2 2023.